Skip to main content

The Burden of Non-Motor Symptoms

  • Chapter
  • First Online:
Handbook of Non-Motor Symptoms in Parkinson's Disease

Abstract

Although most of the symptoms of Parkinson’s disease (PD) seem to be motor-based, the non-motor symptoms (NMSs) of PD, often overshadowed, also constitute a major clinical challenge. The NMSs of PD, including neuropsychiatric, cognitive, gastrointestinal and sensory, not only are observed in later stages but also predominate in the early stages of PD. Research suggests that NMSs are present at onset, while some can precede the motor symptoms, often by many years [1–3]. The identification of premotor stages is based on the early detection of the combination of NMSs with PD detection: for example, olfactory changes are the most common NMS presenting in the early stages of PD and occur in 90 % of the patients [4, 5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Shiba M, Bower JH, Maraganore DM, et al. Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study. Mov Disord 2000;15:669-677.

    Google Scholar 

  2. Iranzo A, Molinuevo JL, Santamaria J, et al. Rapid-eye-movement sleep behavior disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006;5:572-577.

    Google Scholar 

  3. Antonini A. Non-motor symptoms in Parkinson’s disease. Eur Neurol Rev 2009;4:25-27.

    Google Scholar 

  4. Mueller A, Abolmaali ND, Hakimi AR, et al. Olfactory bulb volumes in patients with idiopathic Parkinson’s disease a pilot study. J Neural Transm 2005;112:1363-1370.

    Google Scholar 

  5. Berendse HW. I. 4 Early diagnosis in PD: olfaction. Parkinsonism Rel Disord 2006;12:1-2.

    Google Scholar 

  6. Miyasaki JM, Shannon K, Voon V, et al. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006;66:996-1002.

    Google Scholar 

  7. Forjaz MJ, Frades-Payo B, Martinez-Martin P. [The current state of the art concerning quality of life in Parkinson’s disease: II. Determining and associated factors.] Rev Neurol 2009;49:655-660.

    Google Scholar 

  8. Frades-Payo B, Forjaz MJ, Martinez-Martin P. [The current state of the art concerning quality of life in Parkinson’s disease: I. Instruments, comparative studies and treatments]. Rev Neurol 2009;49:594-598.

    Google Scholar 

  9. Chaudhuri KR, Martinez-Martin P. Quantitation of non-motor symptoms in Parkinson’s disease. Eur J Neurol 2008;15(suppl 2):2-7.

    Google Scholar 

  10. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 2006;21:916-923.

    Google Scholar 

  11. Martinez-Martin P, Schapira AH, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007;22:1623-1629.

    Google Scholar 

  12. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 2010;25:697-701.

    Google Scholar 

  13. Wang G, Wan Y, Cheng Q, et al. Malnutrition and associated factors in Chinese patients with Parkinson’s disease: Results from a pilot investigation. Parkinsonism Relat Disord 2010;16:119-123.

    Google Scholar 

  14. Cervantes-Arriaga A, Rodriguez-Violante M, Villar-Velarde A, Lopez-Gomez M, Corona T. [Metric properties of clinimetric indexes for non-motor dysfunction of Parkinson’s disease in Mexican population.] Rev Invest Clin 2010;62:8-14.

    Google Scholar 

  15. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: Results from an international pilot study. Mov Disord 2007;22:1901-1911.

    Google Scholar 

  16. Honig H, Antonini A, Martinez-Martin P, et al. Intrajejunal levodopa infusion in Parkinson’s disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 2009;24:1468-1474.

    Google Scholar 

  17. Kim HJ, Park SY, Cho YJ, et al. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci 2009;287:200-204.

    Google Scholar 

  18. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, et al. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 2009;73:1584-1591.

    Google Scholar 

  19. Wang G, Hong Z, Cheng Q, et al. Validation of the Chinese Non-Motor Symptoms Scale for Parkinson’s disease: Results from a Chinese pilot study. Clin Neurol Neurosurgery 2009;111:523-526.

    Google Scholar 

  20. Barone P, Antonini A, Colosimo C, et al. The PRIA MO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 2009;24:1641-1649.

    Google Scholar 

  21. Colosimo C, Morgante L, Antonini A, et al. Non-motor symptoms in atypical and secondary parkinsonism: the PRIA MO study. J Neurol 2010;257:5-14.

    Google Scholar 

  22. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-442.

    Google Scholar 

  23. Global Parkinson’s Disease Survey Steering Committee. Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord 2002;17:60-67.

    Google Scholar 

  24. Lohle M, Storch A, Reichmann H. Beyond tremor and rigidity: non-motor features of Parkinson’s disease. J Neural Transm 2009;116:1483-1492.

    Google Scholar 

  25. Wolters EC. Non-motor extranigral signs and symptoms in Parkinson’s disease. Parkinsonism Relat Disord 2009;15(suppl 3):S6-S12.

    Google Scholar 

  26. Qin Z, Zhang L, Sun F, et al. Health related quality of life in early Parkinson’s disease: Impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism. Rel Disord 2009;15:767-771.

    Google Scholar 

  27. Chaudhuri KR, Healy, DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 2006;5:235-245.

    Google Scholar 

  28. Miller E, Berrios GE, Politynska BE. Caring for someone with Parkinson’s disease: factors that contribute to distress. Int J Geriatr Psychiatry 1998;11:263-268.

    Google Scholar 

  29. Carter JH, Stewart BJ, Archbold PG, et al. Living with a person who has Parkinson’s disease: the spouse’s perspective by stage of disease. Mov Disord 2004;13:20-28.

    Google Scholar 

  30. Meara J, Mitchelmore E, Hobson P. Use of the GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson’s disease and their carers in the community. Age Aging 1999;28:35-38.

    Google Scholar 

  31. Habermann B. Spousal perspective of Parkinson’s disease in middle life. J Adv Nurs 2000;31:1409-1415.

    Google Scholar 

  32. Fernandez HH, Tabamo REJ, David RR, Friedman JH. Predictors of depressive symptoms among spouse caregivers in Parkinson’s disease. Mov Disord 2001;16:1123-1125.

    Google Scholar 

  33. Caap-Ahlgren M, Dehlin O. Factors of importance to the caregiver burden experienced by family caregivers of Parkinson’s disease patients. Aging Clin Exp Res 2002;14:371-377.

    Google Scholar 

  34. Edwards NE, Scheetz PS. Predictors of burden for caregivers of patients with Parkinson’s disease. J Neurosci Nurs 2002;34:184-190.

    Google Scholar 

  35. Happe S, Berger K. The association between caregiver burden and sleep disturbances in partners of patients with Parkinson’s disease. Age Ageing 2002;31:349-354.

    Google Scholar 

  36. Thommessen B, Aarsland D, Braekhus A, Oksengaard AR, Engedal K, Laake K. The psychosocial burden on spouses of the elderly with stroke, dementia and Parkinson’s disease. Int J Geriatr Psychiatry 2002;17:78-84.

    Google Scholar 

  37. Martinez-Martin P, Guerrero-Diaz MT, Frades-Payo B. [Neuropsychological disorders in Parkinson’s disease: evaluating them and their impact on the caregiver]. Rev Neurol 2004;39:639-645.

    Google Scholar 

  38. Pal PK, Thennarasu K, Fleming J, Schulzer M, Brown T, Calne SM. Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson’s disease and in their caregivers. Parkinsonism Relat Disord 2004;10:157-168.

    Google Scholar 

  39. Martinez-Martin P, Benito-Leon J, Alonso F, et al. Quality of life of caregivers in Parkinson’s disease. Qual Life Res 2005;14:463-472.

    Google Scholar 

  40. Cifu DX, Carne W, Brown R, et al. Caregiver distress in parkinsonism. J Rehabil Res Dev 2006;43:499-508.

    Google Scholar 

  41. Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiver-burden in Parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord 2006;12:35-41.

    Google Scholar 

  42. Schestatsky P, Zanatto VC, Margis R, et al. Quality of life in a Brazilian sample of patients with Parkinson’s disease and their caregivers. Rev Bras Psiquiatr 2006;28:209-211.

    Google Scholar 

  43. Aarsland D, Bronnick K, Ehrt U, et al. Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007;78:36.

    Google Scholar 

  44. Kim KS, Kim BJ, Kim KH, et al. Subjective and objective caregiver burden in Parkinson’s disease. Taehan Kanho Hakhoe Chi 2007;37:242-248.

    Google Scholar 

  45. Martinez-Martin P, Forjaz MJ, Frades-Payo B, et al. Caregiver burden in Parkinson’s disease. Mov Disord 2007a;22:924-931.

    Google Scholar 

  46. Carter JH, Stewart BJ, Lyons, KS, Archbold, PG. Do motor and nonmotor symptoms in PD patients predict caregiver strain and depression? Mov Disord 2008;23:1211-1216.

    Google Scholar 

  47. Lokk J. Caregiver strain in Parkinson’s disease and the impact of disease duration. Eur J Phys Rehabil Med 2008;44:39-45.

    Google Scholar 

  48. Martinez-Martin P, Arroyo S, Rojo-Abuin JM, Rodriguez-Blazquez C, Frades B, de Pedro CJ. Burden, perceived health status, and mood among caregivers of Parkinson’s disease patients. Mov Disord 2008;23:1673-1680.

    Google Scholar 

  49. D’Amelio M, Terruso V, Palmeri B, et al. Predictors of caregiver burden in partners of patients with Parkinson’s disease. Neurol Sci 2009;30:171-174.

    Google Scholar 

  50. Stella F, Banzato CE, Quagliato EM, Viana MA, Christofoletti G. Psychopathological features in patients with Parkinson’s disease and related caregivers’ burden. Int J Geriatr Psychiatry 2009;24:1158-1165.

    Google Scholar 

  51. Roland KP, Jenkins ME, Johnson AM. An exploration of the burden experienced by spousal caregivers of individuals with Parkinson’s disease. Mov Disord 2010;25:189-193.

    Google Scholar 

  52. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-483.

    Google Scholar 

  53. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.

    Google Scholar 

  54. WHO QOL Group. Development of the World Health Organization WHO QOL-BRE F quality of life assessment. Psychol Med 1998;28:551-558.

    Google Scholar 

  55. Glozman JM, Bicheva KG, Fedorova NV. Scale of quality of life of care-givers (SQLC). J Neurol 1998;245:39-41.

    Google Scholar 

  56. Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 1980;20:649-655.

    Google Scholar 

  57. Novak M, Guest C. Application of a multidimensional caregiver burden inventory. The Gerontologist 1989;29:798-803.

    Google Scholar 

  58. Montgomery RJV, Gonyea JG, Hooyman NR. Caregiving and the experience of subjective and objective burden. Family Relations 1985;34:19-26.

    Google Scholar 

  59. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease. Neurology 2009;72(suppl 4):1-136.

    Google Scholar 

  60. Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson’s disease. Neurology 1993;43:2227-2229.

    Google Scholar 

  61. Guttman M, Slaughter PM, Theriault ME, DeBoer DP, Naylor CD. Burden of parkinsonism: a population-based study. Mov Disord 2002;18:313-319.

    Google Scholar 

  62. Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson’s disease: prevalence and impact on daily life. Clin Autonom Res 2005;15:76-82.

    Google Scholar 

  63. Findley L, Aujla M, Bain PG, et al. Direct economic impact of Parkinson’s disease: a research survey in the United Kingdom. Mov Disord 2003;18:1139-1145.

    Google Scholar 

  64. Cubo E, Martinez-Martin P, Gonzalez M, Frades B, ELEP Group. Impact of motor and non-motor symptoms on the direct costs of Parkinson’s disease [Spanish]. Neurologia 2009;24:15-23.

    Google Scholar 

  65. Dodel RC, Singer M, Kohne-Volland R, et al. The economic impact of Parkinson’s disease: An estimation based on a 3-month prospective analysis. Pharmacoeconomics 1998;14:299-312.

    Google Scholar 

  66. Pålhagen S, Heinonen E, Hagglund J, Kaugesaar T, Maki-Ikola O, Palm R. Selegiline slows the progression of the symptoms of Parkinson disease. Neurology 2006;66:1200-1206.

    Google Scholar 

  67. Haycox A, Armand C, Murteira S, Cochran J, François C. Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson’s disease in the UK setting: An economic Markov model evaluation. Drugs Aging 2009;26:791-801.

    Google Scholar 

  68. Parkinson Study Group. A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease. Arch Neurol 2004;61:561-566.

    Google Scholar 

  69. Olanow CW, Rascol O, Hauser R, et al. A double-blind, delayed-start trial of rasagiline in Parkinson’s disease. N Engl J Med 2009a;361:1268-1278.

    Google Scholar 

  70. Poewe W, Hauser R, Lang AE. Rasagiline 1 mg/day provides benefits in the progression of non-motor symptoms in patients with early Parkinson’s disease: Assessment with the revised MDS-UPDRS. Mov Disord 2009;24:S272-S273.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Healthcare, a part of Springer Science+Business Media

About this chapter

Cite this chapter

Forjaz, M.J., Chandiramani, C., Martinez-Martin, P. (2011). The Burden of Non-Motor Symptoms. In: Handbook of Non-Motor Symptoms in Parkinson's Disease. Springer Healthcare, Heidelberg. https://doi.org/10.1007/978-1-908517-60-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-908517-60-9_2

  • Published:

  • Publisher Name: Springer Healthcare, Heidelberg

  • Print ISBN: 978-1-907673-23-8

  • Online ISBN: 978-1-908517-60-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics